Theratechnologies Inc. Dividends

The next dividend date for Theratechnologies Inc. has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Theratechnologies Inc. (THTX)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Theratechnologies Inc.

Country
USA
Full Time Employees
0

Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its product pipeline includes tesamorelin F8 in HIV-associated lipodystrophy that is in Phase 2 clinical trials for the treatment of nonalcoholic steatohepatitis; SORT1+ Technology that is in Phase 1 clinical trials for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; sudocetaxel zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company also commercializes olezarsen, an RNA-targeted medicine for the treatment of familial chylomicronemia syndrome and severe hypertriglyceridemia; and donidalorsen, an RNA-targeted medicine that targets the acute attacks of hereditary angioedema. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Owning Theratechnologies Inc. Stock on the Dividend Date

If you own Theratechnologies Inc. stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Theratechnologies Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Theratechnologies Inc. stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Theratechnologies Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Theratechnologies Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Theratechnologies Inc. Dividends

You can contact us any time if you would like to ask questions about Theratechnologies Inc. dividends or anything else related to the stock market.